Pascal Soriot, AstraZeneca (AP Images)
April 16, 2020 10:26 AM EDT
People

Pas­cal So­ri­ot, lamenter of low pay, faces in­vestor re­volt for be­ing over­com­pen­sat­ed

Jason Mast

Editor

As­traZeneca CEO Pas­cal So­ri­ot once be­moaned his $13 mil­lion an­nu­al salary, call­ing him­self the “low­est-paid CEO in the whole in­dus­try.”

Now, af­ter his new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times